Results 101 to 110 of about 5,620 (149)

Ascorbic Acid Prevents Loss of Dlk1-Dio3 Imprinting and Facilitates Generation of All-iPS Cell Mice from Terminally Differentiated B Cells [PDF]

open access: yes, 2012
The generation of induced pluripotent stem cells (iPSCs) often results in aberrant epigenetic silencing of the imprinted Dlk1-Dio3 gene cluster, compromising the ability to generate entirely iPSC-derived adult mice ('all-iPSC mice').
Apostolou, Effie   +11 more
core   +1 more source

Epigenetic treatment of solid tumours. A review of clinical trials [PDF]

open access: yes, 2015
Epigenetic treatment has been approved by regulatory agencies for haematological malignancies. The success observe in cutaneous lymphomas represents a proof of principle that similar results may be obtained in solid tumours. Several agents that interfere
CODACCI PISANELLI, Giovanni   +2 more
core   +2 more sources

Therapeutic targeting using tumor specific peptides inhibits long non-coding RNA HOTAIR activity in ovarian and breast cancer [PDF]

open access: yes, 2017
Long non-coding RNAs (lncRNAs) play key roles in human diseases, including cancer. Functional studies of the lncRNA HOTAIR (HOX transcript antisense RNA) provide compelling evidence for therapeutic targeting of HOTAIR in cancer, but targeting lncRNAs in ...
Fang, Fang   +5 more
core   +1 more source

Childhood maltreatment and adult psychopathology: pathways to hypothalamic-pituitary-adrenal axis dysfunction [PDF]

open access: yes, 2009
OBJECTIVE: The aim of this paper was to examine the relationship between childhood maltreatment and adult psychopathology, as reflected in hypothalamic-pituitary-adrenal axis dysfunction.
Carpenter, Linda L.   +5 more
core   +2 more sources

H3.1K27M-induced misregulation of the TONSOKU-H3.1 pathway causes genomic instability

open access: yesNature Communications
The oncomutation lysine 27-to-methionine in histone H3 (H3K27M) is frequently identified in tumors of patients with diffuse midline glioma-H3K27 altered (DMG-H3K27a).
Wenxin Yuan   +10 more
doaj   +1 more source

P10.19.B SINGLE INSTITUTION 15-YEARS EXPERIENCE IN TREATING PEDIATRIC DIFFUSE MIDLINE GLIOMA H3-K27 ALTERED PATIENTS

open access: yesNeuro-Oncology
Abstract BACKGROUND Pediatric diffuse midline gliomas (DMGs), H3 K27-altered, represent the 5-10% of all pediatric brain tumors. The preferential location is the brainstem (diffuse intrinsic pontine glioma, DIPG). Median overall survival is 11 months.
Cacchione, A   +11 more
openaire   +2 more sources

DDEL-19. DRUG-TUMOR RESIDENCE TIME DRIVES EFFICACY OF CONVECTION-ENHANCED DELIVERY IN H3 K27-ALTERED DIFFUSE MIDLINE GLIOMA [PDF]

open access: yesNeuro Oncol
Abstract Advancements in understanding H3 K27-altered diffuse midline glioma (DMG) biology have not yet translated into effective therapies for these tumors likely due to delivery challenges across the blood-brain barrier (BBB) and variable tumor genetics.
Julian S Rechberger   +4 more
europepmc   +2 more sources

Diffuse midline glioma, H3 K27-altered

open access: yes, 2016
Frank Gaillard   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy